Aardvark Therapeutics, Inc. Common Stock Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DECHENG CAPITAL LLC | 05/08/2025 | 3.92 M | $29.42 M | 100.00% | 29.69% |
| CITADEL ADVISORS LLC | 05/15/2025 | 1.27 M | $9.44 M | 100.00% | 9.66% |
| LAURION CAPITAL MANAGEMENT LP | 05/15/2025 | 808.24 K | $6.07 M | 100.00% | 6.13% |
| CORMORANT ASSET MANAGEMENT, LP | 05/15/2025 | 800.19 K | $6.01 M | 100.00% | 6.06% |
| BRAIDWELL LP | 05/15/2025 | 500.00 K | $3.76 M | 100.00% | 3.79% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 312.50 K | $2.35 M | 100.00% | 2.37% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 250.00 K | $1.88 M | 100.00% | 1.89% |
| VANGUARD GROUP INC | 05/09/2025 | 165.49 K | $1.24 M | 100.00% | 1.25% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 143.95 K | $1.08 M | 100.00% | 1.09% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 05/14/2025 | 119.50 K | $897.42 K | 100.00% | 0.91% |
| CANTOR FITZGERALD, L. P. | 05/15/2025 | 66.68 K | $500.78 K | 100.00% | 0.51% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 65.64 K | $492.96 K | 100.00% | 0.50% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 59.60 K | $447.60 K | 100.00% | 0.45% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 35.44 K | $266.12 K | 100.00% | 0.27% |
| BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 34.69 K | $260.52 K | 100.00% | 0.26% |
| BLACKROCK, INC. | 05/02/2025 | 18.78 K | $141.01 K | 100.00% | 0.14% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 15.42 K | $115.83 K | 100.00% | 0.12% |
| UBS GROUP AG | 05/13/2025 | 14.71 K | $110.44 K | 100.00% | 0.11% |
| SQUAREPOINT OPS LLC | 05/15/2025 | 14.19 K | $106.54 K | 100.00% | 0.11% |
| NORTHERN TRUST CORP | 05/13/2025 | 14.00 K | $105.15 K | 100.00% | 0.11% |
| POINT72 (DIFC) LTD | 05/15/2025 | 12.80 K | $96.11 K | 100.00% | 0.10% |
| WALLEYE CAPITAL LLC | 05/14/2025 | 11.73 K | $88.09 K | 100.00% | 0.09% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 4.62 K | $34.70 K | 100.00% | 0.04% |
| JPMORGAN CHASE & CO | 05/12/2025 | 3.10 K | $23.28 K | 100.00% | 0.02% |
| MORGAN STANLEY | 05/15/2025 | 2.22 K | $16.66 K | 100.00% | 0.02% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 05/15/2025 | 1.28 K | $9.64 K | 100.00% | 0.01% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aardvark Therapeutics, Inc. Common Stock institutional Ownership - FAQ's
During the previous two years, 22 institutional investors and hedge funds held shares of Aardvark Therapeutics, Inc. Common Stock. The most heavily invested institutionals were:
Decheng Capital LLC: 3.92 M
CITADEL ADVISORS LLC: 1.27 M
Laurion Capital Management LP: 808,243
Cormorant Asset Management, LP: 800,189
BRAIDWELL LP: 500,000
SUVRETTA CAPITAL MANAGEMENT, LLC: 312,500
65.83% of Aardvark Therapeutics, Inc. Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 8.42 M shares in the last 24 months. This purchase volume represents approximately $93.03 M in transactions.